2025 Speakers

Pharma Thought Leaders

Alberto Calabro

Patient Access Program & Supply Lead

Roche

Annmarie Galli

Head of Global Medical Affairs Research & Compassionate Use, Managed Access Programs

GSK

Antoine Robert

Global Post-Trial Access Lead

Sanofi

Cassandra Slader

Global Head of Managed Access Programs

UCB

Catherine Singfield

Head Senior Director, Eur INT Medical, Evidence Optimisation & Managed Access Programmes Team

Jazz Pharmaceuticals

Helen Dean

Associate Director - Medical Affairs International Operations & Planning

Jazz Pharmaceuticals

Katy Mulleady

.

Abbvie

Lesley Perkin

Patient Advocacy Lead

UCB

Lisa Seifert

Distribution Expert - IMP Delivery

Boehringer Ingelheim

Maja Galic

Head of Global Medical Affairs Operations & Excellence

Teva Pharmaceuticals

Martina Vanek

MAnager for Special Programs

Boehringer Ingelheim

Nicola GIllott

Global Head of Expanded Access

Chiesi

Olga Andreeva

Global Medical Excellence Director

Novo Nordisk

Rachel Harrison

Director, Pre-Approval/Post Trial Access Programs Medical Affairs & Evidence Generation

Argenx

Ramona Reichenbach

Managed Access Center of Excellence Head

Novartis

Sarah Clark

Senior Director, Medical Excellence & Operations

Novo Nordisk

Simon Morgan

Team Lead, Qualified Person

Pfizer

Zoe Zeliku

Associate Director, Clinical Development, Value Evidence & Outcomes, Oncology

GSK

Biotech Thought Leaders

Bethany Bearden, Blueprint Bio, 3rd Operationalise: Early Access Programmes Europe 2024

Bethany Bearden

Associate Director Early Access Operations

Blueprint Medicines

Chiara Troncatti

Head of Business Operations, EMEA

Avidity Biosciences

Dorian Readnour

Executive Director - global patient access

Sarepta Therapeutics

Kjersten Teeter

Director, Head of Medical Affairs Operations

Blueprint Medicines

Mallory Fredericks

Assoc. Director

SpringWorks Therapeutics

MICHELA PANTALEONI

Chief Market Access Officer

Napo Therapeutics

Natalia Kashtalian

Senior Medical Excellence Manager

Sobi

Sara Taglialatela

Global Quality Systems & Compliance, Sr. Director

Kedrion Biopharma

Sarah Moore

Associate Director, Medical Affairs

ImmunoGen Switzerland GmbH (now a part of AbbVie)

Suzanne Webster

Head of International Patient Services

Sarepta Therapeutics

Tamara Popov

Global Medical Affairs Rare Disease Lead

Vifor Pharma

Patient & Advocacy Voices

Charlotte Campbell

Chief Executive Officer

My Aware

Chris Hendriksz

Chief Community Impact Officer

A Rare Cause

Harpreet Ram

Principal

GARDaccess

Tanya Collin-Histed

CEO

International Gaucher Alliance

Trusted Partners

Anne Cropp

Chief Scientific Officer

Early Access Care

Dennis Akkaya

Chief Commercial Officer

myTomorrows

Harry Martin

Portfolio Director, Early Access Programmes

Bionical Emas

Naomi Litchfield

Director, Patient Advocacy

Bionical Emas

Sarah Alummootil

Associate Director - Early Access Programs

Early Access Care